Structure–activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors
Authors:
- Frank RongFrank Rong
- Suetying ChowSCSuetying Chow
- Shunqi YanSYShunqi Yan
- Gary LarsonGLGary Larson
- Zhi HongZHZhi Hong
- Jim WuJWJim Wu
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (6) , 1663-1666
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric SiteJournal of Biological Chemistry, 2005
- Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potencyBioorganic & Medicinal Chemistry Letters, 2004
- Management of hepatitis CJournal of Hepatology, 2003
- Cell-Free Replication of the Hepatitis C Virus Subgenomic RepliconJournal of Virology, 2002
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- Identification and properties of the RNA‐dependent RNA polymerase of hepatitis C virus.The EMBO Journal, 1996
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989